SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-CSPC Pharmaceutical Says Doxorubicin Hydrochloride Liposome Injection Granted Approval By NMPA Of PRC

05/11/2021 11:12
BRIEF-CSPC Pharmaceutical Says Doxorubicin Hydrochloride Liposome Injection Granted Approval By NMPA Of PRC

- CSPC Pharmaceutical Group Ltd 1093.HK:

  • DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION GRANTED APPROVAL BY NMPA OF PRC

Source text for Eikon: ID:nHKS5RGF4M

Further company coverage: 1093.HK


(([email protected];))